Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomised controlled trial.

Sunao KojimaKazuaki UchiyamaNaoto YokotaEiichi TokutakeYutaka WakasaShinya HiramitsuMasako WakiHideaki JinnouchiHirokazu KakudaTakahiro HayashiNaoki KawaiMasahiro SugawaraHisao MoriKenichi TsujitaKunihiko MatsuiIchiro HisatomeYusuke OhyaKazuo KimuraYoshihiko SaitoHisao Ogawanull null

Published in: Rheumatology (Oxford, England) (2021)

ClinicalTrial.gov, https://clinicaltrials.gov, NCT01984749.

Keyphrases

uric acid
metabolic syndrome
subarachnoid hemorrhage
risk assessment
climate change
cerebral ischemia
cerebral blood flow